Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | CHUK | O15111 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14510509 | 0.94 | RAB9A (0.36) | RAB9AMEN1KMT2ATSHRHPGD | |
| SCHEMBL13475210 | 0.87 | RAB9A (0.37) | RAB9AMEN1KMT2ATSHRHPGD | |
| SCHEMBL14666149 | 0.85 | CNR2 (0.35) | MEN1KMT2ATSHRNPC1SMN1; SMN2 | |
| SCHEMBL4262878 | 0.84 | CYP19A1 (0.34) | RAB9AMEN1KMT2ATSHRHPGD | |
| SCHEMBL14666144 | 0.84 | CNR2 (0.33) | RAB9AMEN1KMT2ATSHRHPGD | |
| SCHEMBL13429489 | 0.79 | SMN1; SMN2 (0.39) | RAB9AMEN1KMT2ATSHRHPGD | |
| SCHEMBL2949499 | 0.79 | LPL (0.45) | RAB9AMEN1KMT2ATSHRHPGD | |
| SCHEMBL2956576 | 0.79 | LPL (0.45) | RAB9AMEN1KMT2ATSHRHPGD | |
| SCHEMBL4530065 | 0.79 | LPL (0.45) | RAB9AMEN1KMT2ATSHRHPGD | |
| SCHEMBL7789302 | 0.75 | S1PR5 (0.38) | RAB9AMEN1KMT2ATSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124443-B2 | Organic diodes and materials | MARROCCO MATTHEW L (US) | 2012-02-28 | — | — | US | disclosed |
| US-7714099-B2 | Luminescent compositions and their uses | HITACHI CHEMICAL CO., LTD. (JP) | 2010-05-11 | — | — | US | disclosed |
| US-7714099-B2 | Luminescent compositions and their uses | HITACHI CHEMICAL CO., LTD. (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20100112751-A1 | ORGANIC DIODES AND MATERIALS | MARROCCO III MATTHEW L | 2010-05-06 | — | — | US | disclosed |
| US-20070003783-A1 | Quinoline copolymer and organic electroluminescent device employing same | HITACHI CHEMICAL CO LTD (JP) | 2007-01-04 | — | — | US | disclosed |
| WO-2006041221-A1 | NEW LUMINESCENT COMPOSITIONS AND THEIR USES | HITACHI CHEMICAL CO., LTD. (JP) | 2006-04-20 | — | — | WO | disclosed |
| US-20060083945-A1 | New luminescent compositions and their uses | HITACHI CHEMICAL CO. LTD. (JP) | 2006-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060083945-A1 | New luminescent compositions and their uses | OCIAD1, NLRP3, OCIAD2 | RAB9A 4697/4885MEN1 4288/4885KMT2A 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.